DGAP-News: Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology

DGAP-News: ABIVAX / Key word(s): Study Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the La...

Related Keywords

New York ,United States ,Japan ,Leuven ,Region Flamande ,Belgium ,Paris ,France General ,France ,Regina Jehle ,Enregistrement Universel ,Ghislaine Gasparetto ,Jeanene Timberlake ,Pbruce Sands ,Ligia Vela Reid ,Hartmutj Ehrlich ,Anne Hennecke ,Burrillb Crohn ,Severine Vermeire ,Gastroenterol Hepatol ,Mc Services ,University Hospitals Leuven ,Icahn School Of Medicine At Mount Sinai ,Rooney Partners ,Relations Investors Europe ,Euronext ,Lancet Gastroenterology ,Euronext Paris ,Modified Mayo Score ,Icahn School ,Mount Sinai ,New York City ,Mayo Score ,Although Abivax ,French Autorit ,Des March ,Impact Factor ,Citation Reports ,Lancet Gastroenterol Hepatol ,